1. Home
  2. NCRA vs PRPH Comparison

NCRA vs PRPH Comparison

Compare NCRA & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nocera Inc.

NCRA

Nocera Inc.

N/A

Current Price

$0.83

Market Cap

13.2M

ML Signal

N/A

Logo ProPhase Labs Inc. (DE)

PRPH

ProPhase Labs Inc. (DE)

HOLD

Current Price

$0.52

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCRA
PRPH
Founded
2002
1989
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
4.1M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
NCRA
PRPH
Price
$0.83
$0.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
75.8K
2.7M
Earning Date
04-01-2026
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,106,275.00
$5,055,000.00
Revenue This Year
N/A
$221.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$0.50
52 Week High
$2.40
$9.35

Technical Indicators

Market Signals
Indicator
NCRA
PRPH
Relative Strength Index (RSI) 40.09 59.62
Support Level $0.80 $0.08
Resistance Level $0.95 $1.15
Average True Range (ATR) 0.14 0.07
MACD -0.01 0.06
Stochastic Oscillator 8.66 41.01

Price Performance

Historical Comparison
NCRA
PRPH

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Share on Social Networks: